Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Botond Csiky

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
BMC Nephrology|November 23, 2021
The prognostic role of heart rate recovery after exercise and metabolic syndrome in IgA nephropathyBalázs Sági, István Késői, Tibor Vas, et al.
Journal of Clinical Medicine|December 9, 2023
Acute Vascular Response to Hemodialysis as Measured by Serum Syndecan-1 and Endothelin-1 Levels as Well as Vascular StiffnessBalázs Sági, Szilárd Kun, Rita Klaudia Jakabfi-Csepregi, et al.
Kidney & Blood Pressure Research|December 20, 2017
The Impact of Osteocalcin, Osteoprotegerin and Osteopontin on Arterial Stiffness in Chronic Renal Failure Patients on HemodialysisBotond Csiky, Balázs Sági, Attila Peti, et al.
The International Journal of Cardiovascular Imaging|November 7, 2023
Renal and cardiovascular prognostic significance of echocardiographic early diastolic mitral annular velocity in IgA nephropathyBalázs Sági, István Késői, Tibor Vas, et al.
BMC Nephrology|September 3, 2023
Relationship between arterial stiffness, left ventricular diastolic function, and renal function in chronic kidney diseaseBalázs Sági, István Késői, Tibor Vas, et al.
BMC Nephrology|August 16, 2022
Left ventricular myocardial mass index associated with cardiovascular and renal prognosis in IgA nephropathyBalázs Sági, István Késői, Tibor Vas, et al.
Advances in Therapy|September 15, 2021
Efficacy and Cardiovascular Safety of Roxadustat in Dialysis-Dependent Chronic Kidney Disease: Pooled Analysis of Four Phase 3 StudiesJonathan Barratt, Wladyslaw Sulowicz, Michael Schömig, et al.
Advances in Therapy|September 19, 2021
Roxadustat for the Maintenance Treatment of Anemia in Patients with End-Stage Kidney Disease on Stable Dialysis: A European Phase 3, Randomized, Open-Label, Active-Controlled Study (PYRENEES)Botond Csiky, Michael Schömig, Ciro Esposito, et al.
Lege Artis Medicinae : Uj Magyar Orvosi Hirmondo|February 21, 2009
[The pleiotropic effects of losartan--the importance of decreasing uric acid level]Botond Csiky, Lajos Markó, Márton Mohás, et al.
Physiology International|July 4, 2020
Pro- and anti-inflammatory factors, vascular stiffness and outcomes in chronic hemodialysis patientsB Sági, A Peti, O Lakatos, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
BMC Nephrology|November 23, 2021
The prognostic role of heart rate recovery after exercise and metabolic syndrome in IgA nephropathyBalázs Sági, István Késői, Tibor Vas, et al.
Journal of Clinical Medicine|December 9, 2023
Acute Vascular Response to Hemodialysis as Measured by Serum Syndecan-1 and Endothelin-1 Levels as Well as Vascular StiffnessBalázs Sági, Szilárd Kun, Rita Klaudia Jakabfi-Csepregi, et al.
Kidney & Blood Pressure Research|December 20, 2017
The Impact of Osteocalcin, Osteoprotegerin and Osteopontin on Arterial Stiffness in Chronic Renal Failure Patients on HemodialysisBotond Csiky, Balázs Sági, Attila Peti, et al.
The International Journal of Cardiovascular Imaging|November 7, 2023
Renal and cardiovascular prognostic significance of echocardiographic early diastolic mitral annular velocity in IgA nephropathyBalázs Sági, István Késői, Tibor Vas, et al.
BMC Nephrology|September 3, 2023
Relationship between arterial stiffness, left ventricular diastolic function, and renal function in chronic kidney diseaseBalázs Sági, István Késői, Tibor Vas, et al.
BMC Nephrology|August 16, 2022
Left ventricular myocardial mass index associated with cardiovascular and renal prognosis in IgA nephropathyBalázs Sági, István Késői, Tibor Vas, et al.
Advances in Therapy|September 15, 2021
Efficacy and Cardiovascular Safety of Roxadustat in Dialysis-Dependent Chronic Kidney Disease: Pooled Analysis of Four Phase 3 StudiesJonathan Barratt, Wladyslaw Sulowicz, Michael Schömig, et al.
Advances in Therapy|September 19, 2021
Roxadustat for the Maintenance Treatment of Anemia in Patients with End-Stage Kidney Disease on Stable Dialysis: A European Phase 3, Randomized, Open-Label, Active-Controlled Study (PYRENEES)Botond Csiky, Michael Schömig, Ciro Esposito, et al.
Lege Artis Medicinae : Uj Magyar Orvosi Hirmondo|February 21, 2009
[The pleiotropic effects of losartan--the importance of decreasing uric acid level]Botond Csiky, Lajos Markó, Márton Mohás, et al.
Physiology International|July 4, 2020
Pro- and anti-inflammatory factors, vascular stiffness and outcomes in chronic hemodialysis patientsB Sági, A Peti, O Lakatos, et al.
Pageof 4